Circulating <scp>CD22</scp> +/ <scp>CD19</scp> −/ <scp>CD24</scp> − progenitors and <scp>CD22</scp> +/ <scp>CD19</scp> +/ <scp>CD24</scp> − mature B cells: Diagnostic pitfalls for minimal residual disease detection in <scp>B‐lymphoblastic</scp> leukemia-Reference-Cited by-同舟云学术

Circulating CD22 +/ CD19 −/ CD24 − progenitors and CD22 +/ CD19 +/ CD24 − mature B cells: Diagnostic pitfalls for minimal residual disease detection in B‐lymphoblastic leukemia

Published:2022-11-26 Issue: Volume: Page:
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry Part B Clinical

Author:

Zhou Ting¹,Karrs Jeremiah¹,Ho Truc¹,Doverte Alyssa¹,Kochenderfer James N.²,Shah Nirali N.³,Yuan Constance M.¹^ORCID,Wang Hao‐Wei¹^ORCID

Affiliation:

1. Laboratory of Pathology, Center for Cancer Research National Cancer Institute, National Institutes of Health Bethesda Maryland USA

2. Surgery Branch, Center for Cancer Research National Cancer Institute, National Institutes of Health Bethesda Maryland USA

3. Pediatric Oncology Branch, Center for Cancer Research National Cancer Institute, National Institutes of Health Bethesda Maryland USA

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.22104

Reference25 articles.

1. Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL

2. Mature B-cell lymphoblastic leukemia with MLL rearrangement: an uncommon and distinct subset of childhood acute leukemia

3. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

4. Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children’s Oncology Group study AALL0232

5. Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Faster clinical decisions in B‐cell acute lymphoblastic leukaemia: A single flow cytometric 12‐colour tube improves diagnosis and minimal residual disease follow‐up;British Journal of Haematology;2024-03-03

2. Deciphering stage 0 hematogones by flow cytometry in follow‐up bone marrow samples of pediatric B—Acute lymphoblastic leukemia cases: A potential mimicker of residual disease after anti CD19 therapy;Cytometry Part B: Clinical Cytometry;2024-01-19

3. Issue highlights—September 2023;Cytometry Part B: Clinical Cytometry;2023-09

4. Issue highlights—July 2023;Cytometry Part B: Clinical Cytometry;2023-07